Azman’s record
His HbA1c record, as one line
Type 2 diabetes and high blood pressure. Seven HbA1c results since December 2023: 8.6 down to 7.2, back up to 7.9 in August 2026.
Move along the line to read it.
From today
100 possible futures
At now, the line splits into 100 possible futures for his next HbA1c: 68 land between 7.0 and 7.9, 17 between 6.5 and 6.9, 10 between 8.0 and 8.9.
Point at a band to read it.
Research preview for clinicians, not a diagnosis.
Most likely next
Counted out of 100, with the 80% interval
- eGFR worse in 12 months
31of 100 futures, 80% interval 15 to 47
Tested on held-out synthetic cases: model 0.82, simple baseline 0.63 - HbA1c 8.0 or higher next test
12of 100 futures, 80% interval 1 to 35
Tested on held-out synthetic cases: model 0.91, simple baseline 0.87 - Eye screening overdue
By rule, not the model
Last screened 15 months ago; due every 12.
Shown only where the model beat a simple baseline. These figures are calibrated, so they can differ by one from the bands.
Two futures
Same 100 futures, run twice
As it stands, 0 of 100 futures include a visit within 4 weeks. With the Agents’ recall approved today, 62 of 100 do (80% interval 56 to 68). Only the recall differs.
The cost of acting
Missed follow-ups stay the same
Missed follow-ups in 90 days: 7 to 21 of 100 (80% interval), with or without the recall. Calibrated, like the list above.
- A visit within 4 weeks0 → 62 of 100
- Missed follow-up in 90 days7 to 21 of 100
A person decides
Nothing goes out without approval
The Agents draft the clinic’s approved check-up message. It names no test or condition and waits for the front desk.
It is time for your check-up at the clinic. Reply to choose a day that suits you.
Plainly
A research preview for clinicians to weigh, not a diagnosis
- Real product output for one patient record, pulled 13 November 2026.
- Every figure has its 80% interval, and the model shows only where it beat a simple baseline.
- Trained on synthetic patients and not validated for any clinic’s patients. The front desk decides what is sent.
Image credits: kidney and pancreas, NIH BioArt (NIAID), public domain; eye section, National Eye Institute, public domain. Redrawn as line art.
.svg){kind=link}
